Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026
Pulmonx Shares Fall Following Recent Gains
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pulmonx Corporation (LUNG) Now Trades Above Golden Cross: Time to Buy?
Pulmonx Rebuilds Sales Force, Targets Growth and AeriSeal Launch Next Year
What Makes Pulmonx Corporation (LUNG) a Strong Momentum Stock: Buy Now?
Pulmonx (LUNG) Q2 2026 Earnings Call Transcript
Pulmonx (LUNG) Upgraded to Buy: What Does It Mean for the Stock?
Pulmonx Corporation Q2 2026 Earnings Call Summary
Pulmonx Corporation (LUNG) Q2 2026 Earnings Call Transcript
Pulmonx Q2 Earnings Call Highlights
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Pulmonx (NASDAQ:LUNG) Jumps 8%+ After Q2 Earnings Beat on Improving Operating Leverage
Pulmonx Reports Second Quarter 2026 Financial Results
Pulmonx Affirms FY2026 Sales Guidance of $90.000M-$92.000M vs $90.832M Est
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026
Pulmonx Corporation (LUNG) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Pulmonx (LUNG) Q1 2026 Earnings Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.